Influenza H7N9 virus disrupts the monolayer human brain microvascular endothelial cells barrier in vitro

Yuxuan Lei1, Ying Sun2, Weihua Wu2

  • 1School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.

Virology Journal
|September 29, 2023
PubMed

Insights

The Influenza H7N9 virus can infect brain cells, damaging the blood-brain barrier. This finding offers a potential explanation for H7N9-related brain damage and neurological complications.

Area of Science:

  • Virology
  • Neuroscience
  • Immunology

Background:

  • Influenza H7N9 (H7N9) infection has a high fatality rate, often causing pneumonia.
  • While pneumonia is linked to cytokine storms, the mechanism of H7N9's central nervous system (CNS) complications remains unclear.

Purpose of the Study:

  • To investigate the pathogenic mechanism of H7N9-induced central nervous system complications.
  • To determine if the H7N9 virus can compromise blood-brain barrier (BBB) integrity.

Main Methods:

  • Utilized immortalized human brain microvascular endothelial cells (hCMEC/D3) to model the BBB.
  • Assessed the effect of H7N9 virus infection on BBB integrity and permeability.
  • Measured the expression of key cell junction proteins: claudin-5, occludin, and VE-cadherin.

Main Results:

  • Demonstrated that the H7N9 virus can infect brain microvascular endothelial cells.
  • Showed that H7N9 infection compromises BBB integrity and increases permeability.
  • Observed down-regulation of cell junction proteins (claudin-5, occludin, VE-cadherin) following H7N9 infection.

Conclusions:

  • H7N9 virus can infect and impair the function of the blood-brain barrier in vitro.
  • BBB dysfunction by H7N9 infection is a potential mechanism underlying H7N9 viral encephalopathy.

Related Concept Videos